Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Launches Lockable ICRplus Settle Plates

Published: Wednesday, October 30, 2013
Last Updated: Wednesday, October 30, 2013
Bookmark and Share
Suitable for use in isolators and clean rooms.

Merck Millipore has launched lockable ICRplus Settle Plates for viable air monitoring and personnel monitoring in clean rooms and isolators.

The new plates are based on the original Merck Millipore ICR Settle Plate technology and provide semi-quantitative determination of microbial contamination.

ICRplus Settle Plates feature a new two-way closure system: the "CLOSED" position allows safe transportation and aerobic incubation while the "VENT" position expands incubation for the detection of anaerobic and microaerophilic microorganisms.

ICRplus Settle Plates are filled with Casein Soybean Digest Agar (TSA), which is recommended by the Food and Drug Administration (FDA) Guidance for Industry (2004): Sterile Drug Products Produced by Aseptic Processing - cGMP.

The plates are offered in formulations with neutralizers for the inactivation of disinfectant. Additionally, the plates can be utilized for the detection of fastidious bacteria when used in combination with Chocolate Agar and lecithin, Tween® 80 and histidine (LTH).

"Efficient and reliable environmental monitoring of isolators and clean rooms is essential to support product quality and customer safety," said Yvonne Hochheimer, Product Manager at Merck Millipore.

Hochheimer continued, "With our unique two-way closure system of the ICRplus Settle Plates, customers can be assured of safer transport and reliable detection of aerobic and anaerobic microorganisms. The plates also offer the ultimate in convenience with room temperature storage at the site of use and a long shelf life. This translates into decreased storage costs and fewer incoming goods controls and QC testing."

ICRplus Settle Plates are produced under aseptic conditions, gamma-irradiated and triple-bagged, making them optimal for personnel monitoring, passive air sampling and active air sampling with sieve like samplers (e.g., MAS air samplers) in isolators and clean rooms.

Furthermore the new products enable inactivation of residual vaporous hydrogen peroxide (VHP) during active air sampling.

Each ICRplus Settle Plate contains a data matrix barcode, which allows secure identification of plates and supports the "paperless" lab. The 90 mm plates have a high filling volume of 30 ml, which allows prolonged incubation.

With the new ICRplus Settle Plates, Merck Millipore stands out as the first supplier of a complete portfolio of lockable, ready-to-use settle and contact plates (ICRplus contact plates) for environmental monitoring in the pharmaceutical industry.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore, VWR Extend Western European Distribution Agreement
Provides VWR access to more Merck Millipore products and reagents for chemical and microbiological analysis.
Wednesday, April 09, 2014
Merck Millipore Announces New Genomic Biomarker Services
Genetic and epigenetic technologies added to established CRO services for biomarker development, validation and testing.
Wednesday, December 05, 2012
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!